APA (7th ed.) Citation

Teng, X., Li, S., Zhang, C., Ding, H., Tian, Z., Zhu, Y., . . . Lu, Z. (2025). NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors. Experimental Hematology & Oncology, 14(1), 1. https://doi.org/10.1186/s40164-025-00646-3

Chicago Style (17th ed.) Citation

Teng, Xia, et al. "NKG2D/CD28 Chimeric Receptor Boosts Cytotoxicity and Durability of CAR-T Cells for Solid and Hematological Tumors." Experimental Hematology & Oncology 14, no. 1 (2025): 1. https://doi.org/10.1186/s40164-025-00646-3.

MLA (9th ed.) Citation

Teng, Xia, et al. "NKG2D/CD28 Chimeric Receptor Boosts Cytotoxicity and Durability of CAR-T Cells for Solid and Hematological Tumors." Experimental Hematology & Oncology, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40164-025-00646-3.